Article

Perioperative management of antiplatelet-drugs in cardiac surgery.

Department of Anaesthesiology and Critical Care Medicine, Hospital Clínic Universitari, València, Spain.
Current Cardiology Reviews 05/2009; 5(2):125-32. DOI: 10.2174/157340309788166688
Source: PubMed

ABSTRACT The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery under an altered platelet function also means an increased risk of bleeding in the perioperative period. Because of the conflict recommendations, this review article tries to evaluate the outcome of different perioperative antiplatelet protocols in patients with coronary artery disease undergoing CABG.

0 Bookmarks
 · 
226 Views

Full-text (2 Sources)

Download
58 Downloads
Available from
May 28, 2014